HK1134901A1 - Radioactive diagnostic imaging agent - Google Patents

Radioactive diagnostic imaging agent

Info

Publication number
HK1134901A1
HK1134901A1 HK09111939.2A HK09111939A HK1134901A1 HK 1134901 A1 HK1134901 A1 HK 1134901A1 HK 09111939 A HK09111939 A HK 09111939A HK 1134901 A1 HK1134901 A1 HK 1134901A1
Authority
HK
Hong Kong
Prior art keywords
imaging agent
diagnostic imaging
radioactive diagnostic
radioactive
agent
Prior art date
Application number
HK09111939.2A
Other languages
English (en)
Inventor
Akio Hayashi
Toshiyuki Shinmura
Daisaku Nakamura
Soichi Nakamura
Shinji Tokunaga
Emi Kaneko
Masahito Toyama
Original Assignee
Nihon Mediphysics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nihon Mediphysics Co Ltd filed Critical Nihon Mediphysics Co Ltd
Publication of HK1134901A1 publication Critical patent/HK1134901A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds
    • A61K51/0404—Lipids, e.g. triglycerides; Polycationic carriers
    • A61K51/0406—Amines, polyamines, e.g. spermine, spermidine, amino acids, (bis)guanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
    • C07B59/001—Acyclic or carbocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
    • A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
    • A61K51/04—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Physics & Mathematics (AREA)
  • Optics & Photonics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
HK09111939.2A 2006-12-21 2009-12-18 Radioactive diagnostic imaging agent HK1134901A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006343753 2006-12-21
PCT/JP2007/072444 WO2008075522A1 (fr) 2006-12-21 2007-11-20 Agent d'imagerie de diagnostic radioactif

Publications (1)

Publication Number Publication Date
HK1134901A1 true HK1134901A1 (en) 2010-05-20

Family

ID=39536156

Family Applications (1)

Application Number Title Priority Date Filing Date
HK09111939.2A HK1134901A1 (en) 2006-12-21 2009-12-18 Radioactive diagnostic imaging agent

Country Status (16)

Country Link
US (1) US8790620B2 (fr)
EP (1) EP2106808B1 (fr)
JP (1) JP5159636B2 (fr)
KR (2) KR101579796B1 (fr)
CN (1) CN101563107B (fr)
AU (1) AU2007335633A1 (fr)
BR (1) BRPI0721157A2 (fr)
CA (1) CA2672262C (fr)
ES (1) ES2663696T3 (fr)
HK (1) HK1134901A1 (fr)
NO (1) NO343137B1 (fr)
PL (1) PL2106808T3 (fr)
PT (1) PT2106808T (fr)
RU (1) RU2445120C2 (fr)
TW (1) TWI409083B (fr)
WO (1) WO2008075522A1 (fr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PT1978015T (pt) 2005-11-29 2018-03-26 Nihon Mediphysics Co Ltd Composto precursor de composto orgânico marcado com halogéneo radioativo
ES2421886T3 (es) * 2007-02-13 2013-09-06 Nihon Mediphysics Co Ltd Método para producción de un agente de representación de imágenes de diagnóstico por radiación
CN103270004A (zh) 2010-12-29 2013-08-28 通用电气健康护理有限公司 洗脱溶液
US11534494B2 (en) 2011-12-21 2022-12-27 Ge Healthcare Limited Formulation and method of synthesis
GB201411569D0 (en) 2014-06-30 2014-08-13 Ge Healthcare Ltd Novel formulation and method of synthesis
RU2623163C2 (ru) * 2011-12-21 2017-06-22 ДжиИ ХЕЛТКЕР ЛИМИТЕД Композиция 18f- флуцикловина в цитратных буферах
GB201305687D0 (en) * 2013-03-28 2013-05-15 Ge Healthcare Ltd Radiolabelling process

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2756593B2 (ja) 1989-09-01 1998-05-25 日本鋼管株式会社 地中掘削装置
JPH0443497A (ja) 1990-06-09 1992-02-13 Omron Corp 多車線対応型車両感知器
JPH0456725A (ja) 1990-06-26 1992-02-24 Sumitomo Metal Ind Ltd 加工性に優れた熱延鋼板の製造方法
US5849261A (en) * 1991-02-08 1998-12-15 Diatide, Inc. Radiolabeled vasoactive intestinal peptides for diagnosis and therapy
ES2079994B1 (es) * 1992-10-07 1996-08-01 Cusi Lab Formulacion farmaceutica a base de polimixina-trimetoprim y un agente antiinflamatorio para su utilizacion topica oftalmica y otica.
EP0859642A2 (fr) * 1995-10-17 1998-08-26 G.D. Searle & Co. Procede de detection de la cyclooxygenase-2
JP4242465B2 (ja) 1996-09-18 2009-03-25 日本メジフィジックス株式会社 放射線防護剤
US6027710A (en) * 1996-09-18 2000-02-22 Nihon Medi-Physiscs Co., Ltd. Radiation-protecting agent
US6812327B1 (en) * 1996-10-25 2004-11-02 Human Genome Sciences, Inc. Neutrokine-alpha polypeptides
US6017706A (en) * 1997-05-07 2000-01-25 The United States Of America As Represented By The Department Of Health And Human Services Process for identifying compounds which protect against the formation of fluorescent light induced DNA lesions and x-ray-induced lesions
BR0207315A (pt) * 2001-02-26 2004-02-10 Bristol Myers Squibb Pharma Co Análogos de ácido ascórbico para metalorradiofármacos
EP1356827A1 (fr) 2002-04-24 2003-10-29 Mallinckrodt Inc. Préparation d'une solution de 2-18F-fluoro-2-déoxy-D-glucose (18F-FDG)
ES2347535T3 (es) 2002-11-05 2010-11-02 Ion Beam Applications S.A. Estabilizacion de composiciones acuosas de 2-fluoro-2-desoxi-d-glucosa marcada con el isotopo 18f con etanol.
KR100508518B1 (ko) 2002-11-13 2005-08-17 한미약품 주식회사 초임계유체 공정을 이용한 파클리탁셀 고체분산체의 제조방법 및 이 방법으로 제조된 파클리탁셀 고체분산체
GB0229695D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase preparation of 18F-labelled amino acids
GB0422004D0 (en) 2004-10-05 2004-11-03 Amersham Plc Method of deprotection
CN101180272B (zh) * 2005-05-23 2012-04-25 日本医事物理股份有限公司 有机化合物及利用该化合物的放射性卤素标记有机化合物的制造方法
US20060292073A1 (en) * 2005-06-23 2006-12-28 Emory University Stereoselective Synthesis of Amino Acid Analogs for Tumor Imaging
ES2421886T3 (es) 2007-02-13 2013-09-06 Nihon Mediphysics Co Ltd Método para producción de un agente de representación de imágenes de diagnóstico por radiación

Also Published As

Publication number Publication date
CN101563107A (zh) 2009-10-21
PL2106808T3 (pl) 2018-07-31
BRPI0721157A2 (pt) 2014-04-01
KR101579796B1 (ko) 2015-12-24
EP2106808A1 (fr) 2009-10-07
KR20090094081A (ko) 2009-09-03
NO343137B1 (no) 2018-11-19
TW200826964A (en) 2008-07-01
TWI409083B (zh) 2013-09-21
JPWO2008075522A1 (ja) 2010-04-08
CA2672262A1 (fr) 2008-06-26
EP2106808B1 (fr) 2018-02-21
RU2009128055A (ru) 2011-01-27
AU2007335633A1 (en) 2008-06-26
ES2663696T3 (es) 2018-04-16
US8790620B2 (en) 2014-07-29
NO20092382L (no) 2009-09-16
RU2445120C2 (ru) 2012-03-20
PT2106808T (pt) 2018-03-26
KR101497406B1 (ko) 2015-03-02
US20100028258A1 (en) 2010-02-04
KR20150004940A (ko) 2015-01-13
CA2672262C (fr) 2016-07-05
CN101563107B (zh) 2012-07-11
WO2008075522A1 (fr) 2008-06-26
EP2106808A4 (fr) 2013-02-27
JP5159636B2 (ja) 2013-03-06

Similar Documents

Publication Publication Date Title
GB0716885D0 (en) Diagnostic agent
EP1980207A4 (fr) Imageur radiographique
EP2086400A4 (fr) Dispositif de diagnostic médical amélioré
EP1976274A4 (fr) Dispositif d'imagerie
HK1106906A1 (en) Imaging device
GB0602380D0 (en) Imaging system
EP2018048A4 (fr) Systeme imageur
GB0610395D0 (en) Novel imaging agents
EP2063783A4 (fr) Système d'imagerie dentaire complexe
EP1996078A4 (fr) Système d'imagerie
EP2085032A4 (fr) Système général d'imagerie
IL187945A (en) Medical Imaging Systems
EP2001222A4 (fr) Dispositif d'imagerie
EP2050396A4 (fr) Dispositif d'imagerie par rayonnement
EP1862118A4 (fr) Systeme d'imagerie radiographique
EP2000096A4 (fr) Dispositif d'imagerie par ultrasons
IL211526A0 (en) Compounds and methods for 18f labeled agents, compositions comprising such compounds and their use for diagnostic imaging
HK1106125A1 (en) Imaging system
EP1994873A4 (fr) Dispositif d'imagerie
EP1974674A4 (fr) Système d'imagerie
EP2063784A4 (fr) Appareil d'imagerie radiologique médicale
HK1134901A1 (en) Radioactive diagnostic imaging agent
GB2435977B (en) Imaging system
EP2087842A4 (fr) Dispositif d'imagerie
EP2031862A4 (fr) Dispositif de formation d'image